Researcher.Life Logo

Journal of Dermatological Treatment : Impact Factor & More

eISSN: 1471-1753pISSN: 0954-6634
JournalOpen Access

Aims and Scope of Journal of Dermatological Treatment

The Journal of Dermatological Treatment is a bimonthly peer-reviewed medical journal that covers all aspects of the treatment of skin disease, including the use of topical and systematically administered drugs and other forms of therapy. It is published by Informa Healthcare and the editors-in-chief are Peter van de Kerkhof (Radboud University Nijmegen) and Steven R. Feldman (Wake Forest University School of Medicine). The journal is available online and in paper format. Less

Key Metrics

CiteScore
5
Impact Factor
< 5
SJR
Q2Dermatology
SNIP
1.1
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Dermatological Treatment

Journal of Dermatological Treatment Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Bi-monthly
Article Processing ChargesAUD 4780 | EUR 3190 | GBP 2750 | USD 3500
Publication Time7
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year1989
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 7
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Journal of Dermatological Treatment ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Dermatological Treatment

Injectable platelet-rich fibrin as a valid therapeutic option for inactive linear morphea (en coup de saber): report of cases
  • 31 Dec 2026
  • Journal of Dermatological Treatment
Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids
  • 31 Dec 2026
  • Journal of Dermatological Treatment
Dose-dependent effectiveness and patient-reported outcomes with JAK1 inhibitors in atopic dermatitis: a 36-week multicenter real-world cohort
  • 31 Dec 2026
  • Journal of Dermatological Treatment
Raising the bar of efficacy in Atopic Dermatitis: deep response in week 16 responders treated with lebrikizumab over 2 years
  • 31 Dec 2026
  • Journal of Dermatological Treatment
Healthcare resource use of patients with mild-moderate psoriasis on systemic treatments: a UK single-center longitudinal retrospective cohort study
  • 31 Dec 2026
  • Journal of Dermatological Treatment
‘Oral isotretinoin plus desloratadine for acne vulgaris: an updated global meta-analysis of efficacy, safety, and patient-centered outcomes’
  • 31 Dec 2026
  • Journal of Dermatological Treatment
Injectable platelet-rich fibrin as a valid therapeutic option for inactive linear morphea (en coup de saber): report of cases
  • 31 Dec 2026
  • Journal of Dermatological Treatment
Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids
  • 31 Dec 2026
  • Journal of Dermatological Treatment
Dose-dependent effectiveness and patient-reported outcomes with JAK1 inhibitors in atopic dermatitis: a 36-week multicenter real-world cohort
  • 31 Dec 2026
  • Journal of Dermatological Treatment
Raising the bar of efficacy in Atopic Dermatitis: deep response in week 16 responders treated with lebrikizumab over 2 years
  • 31 Dec 2026
  • Journal of Dermatological Treatment
Healthcare resource use of patients with mild-moderate psoriasis on systemic treatments: a UK single-center longitudinal retrospective cohort study
  • 31 Dec 2026
  • Journal of Dermatological Treatment
‘Oral isotretinoin plus desloratadine for acne vulgaris: an updated global meta-analysis of efficacy, safety, and patient-centered outcomes’
  • 31 Dec 2026
  • Journal of Dermatological Treatment

FAQs on Journal of Dermatological Treatment